New Potential Weapons for Refractory Scleritis in the Era of Targeted Therapy

• Váldodahkkit: Claudia Fabiani (Dahkki), Jurgen Sota (Dahkki), Maite Sainz- (Dahkki), Laura Pelegrín (Dahkki), Giacomo Emmi (Dahkki), Giuseppe Lopalco (Dahkki), Florenzo Iannone (Dahkki), Lorenzo Vannozzi (Dahkki), Silvana Guerriero (Dahkki), Maria Chiara Gelmi (Dahkki), Donato Rigante (Dahkki), Gian Marco Tosi (Dahkki), José Hernández-Rodríguez (Dahkki), Luca Cantarini (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Hindawi Limited, 2020-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Objective. To assess the efficacy of biologic drugs, beyond tumor necrosis factor- (TNF-) α inhibitors, in the management of noninfectious refractory scleritis, either idiopathic or associated with systemic immune-mediated disorders. Patients and Methods. This is a retrospective study assessing the...